Related Experiment Video
Updated: Dec 30, 2025

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment
Eleni Maniati1, Chiara Berlato1, Ganga Gopinathan1
1Barts Cancer Institute, Queen Mary University of London, London EC1M 6BQ, UK.
Abstract:
Although there are many prospective targets in the tumor microenvironment (TME) of high-grade serous ovarian cancer (HGSOC), pre-clinical testing is challenging, especially as there is limited information on the murine TME. Here, we characterize the TME of six orthotopic, transplantable syngeneic murine HGSOC lines established from genetic models and compare these to patient biopsies. We identify significant correlations between the transcriptome, host cell infiltrates, matrisome, vasculature, and tissue modulus of mouse and human TMEs, with several stromal and malignant targets in common. However, each model shows distinct differences and potential vulnerabilities that enabled us to test predictions about response to chemotherapy and an anti-IL-6 antibody. Using machine learning, the transcriptional profiles of the mouse tumors that differed in chemotherapy response are able to classify chemotherapy-sensitive and -refractory patient tumors. These models provide useful pre-clinical tools and may help identify subgroups of HGSOC patients who are most likely to respond to specific therapies.
Insights
New murine models of high-grade serous ovarian cancer (HGSOC) mimic the human tumor microenvironment (TME). These models predict patient response to chemotherapy and targeted therapies, aiding drug development.
Area of Science:
- Oncology
- Cancer Biology
- Translational Research
Background:
- The tumor microenvironment (TME) is a complex system crucial for high-grade serous ovarian cancer (HGSOC) progression.
- Pre-clinical testing of potential therapies for HGSOC is hindered by limited understanding of the murine TME.
- Developing accurate pre-clinical models is essential for advancing HGSOC treatment strategies.
Observation:
- Six orthotopic, transplantable syngeneic murine HGSOC lines were established and characterized.
- The murine TME was compared to human HGSOC patient biopsies.
- Correlations were identified between the transcriptome, host cell infiltrates, matrisome, vasculature, and tissue modulus in both mouse and human TMEs.
Findings:
- Significant correlations were observed between murine and human TMEs, revealing common stromal and malignant targets.
- Distinct differences and potential vulnerabilities were identified in each murine model.
- Machine learning analysis of transcriptional profiles from mouse models successfully classified chemotherapy-sensitive and -refractory patient tumors.
Implications:
- These characterized murine HGSOC models serve as valuable pre-clinical tools for therapeutic testing.
- The models can help predict patient responses to chemotherapy and targeted agents like anti-IL-6 antibodies.
- This research may facilitate the identification of HGSOC patient subgroups likely to benefit from specific therapies.
More Related Videos
08:17Murine Experimental Model of Original Tumor Development and Peritoneal Metastasis via Orthotopic Inoculation with Ovarian Carcinoma Cells
Published on: December 9, 2016
10:35An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses
Published on: November 28, 2010